Related Experiment Video

Updated: Jul 10, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Use of interleukin-2 in immunotherapy of human immunodeficiency virus infection

A Reier1, R T Mitsuyasu

  • 1UCLA Center for Clinical AIDS Research and Education, Los Angeles, California 90095-1793, USA.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|November 21, 2007
PubMed

Interleukin-2 (IL-2) is a cytokine produced by activated T cells. Its stimulatory activity allows T cells, B cells and natural killer cells to proliferate and to release cytokines and antibodies which protect the host against invading organisms. IL-2 plays a critical role in the prevention of apoptosis of HIV-infected cells, and the addition of IL-2 to a culture medium will increase the survival of T cells and will upregulate IL-2 receptor function. Clinical studies of the administration of exogenous IL-2 to HIV-infected patients have demonstrated that it can be given in well tolerated doses and that it can increase and sustain the number of CD4+ cells while only transiently affecting viral proliferation, especially when given to patients with CD4+ counts >200 cells/mm(3). Further investigations are required to determine the optimal use of exogenous IL-2 in HIV-infected patients. There may also be an important role for IL-2 as an adjunct to gene therapy and preventive vaccines against HIV infection.

More Related Videos

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays12:07

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays

Published on: March 14, 2011

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.